Form 8-K - Current report:
SEC Accession No. 0001964738-26-000031
Filing Date
2026-05-27
Accepted
2026-05-27 16:23:24
Documents
12
Period of Report
2026-05-21
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K solv-20260521.htm   iXBRL 8-K 30765
2 EX-10.1 a101-solventumexecutivesev.htm EX-10.1 160549
  Complete submission text file 0001964738-26-000031.txt   335012

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT solv-20260521.xsd EX-101.SCH 1801
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT solv-20260521_lab.xml EX-101.LAB 21629
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT solv-20260521_pre.xml EX-101.PRE 12524
15 EXTRACTED XBRL INSTANCE DOCUMENT solv-20260521_htm.xml XML 2711
Mailing Address 1750 YANKEE DOODLE ROAD EAGAN MN 55121
Business Address 1750 YANKEE DOODLE ROAD EAGAN MN 55121 651-733-1110
Solventum Corp (Filer) CIK: 0001964738 (see all company filings)

EIN.: 922008841 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41968 | Film No.: 261026505
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)